LQDA Liquidia Corporation Operating Margin

Liquidia Technologies (LQDA) - corporate logo

The business stability of Liquidia Corporation (LQDA) is limited by its dependence on external supply chains and geopolitical risks. The operating margin reflects profit dynamics, where 47.10 is recorded as the baseline value. While the company's growth relies on the commercialization of Treprostinil and patent successes, its critical concentration in a single therapeutic area necessitates an urgent portfolio expansion to mitigate overall risks.

LQDA: liquidia.com Return on Sales by Operating Profit 07/04/2022 - 11/20/2026

Analytical breakdowns and data insights for company Liquidia (LQDA)

Fundamental company valuation:Liquidia Inc., LQDA
Finished products of liquidia.com

Operating margin determines the share of profit from core operations relative to total revenue, serving as a fundamental indicator of cost management efficiency before accounting for financial and tax obligations. By analyzing the operating margin timeline, an investor will see Liquidia Corporation (LQDA) transition toward profitability following the resolution of legal disputes and the scaling of Yutrepia sales within the pulmonary hypertension therapy market.

Analysis of competing companies

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|Galapagos N.V. (GLPG) - Operating Profitability|anipharmaceuticals.com - Operating Profit Rate|Operating Sales Margin MNKD|AMPH: Operating Profit Rate|Operating Profitability pacira.com (PCRX)|Operating Margin ARS Pharma (SPRY)|Theravance Biopharma - Operating Sales Margin|Operating Profit Ratio AQST (Aquestive Therapeutics)|SCPH: Operating Sales Margin|Operating Return on Sales Tectonic Therapeutic|TNXP: Operating Margin|SXT China (SXTC) - Operating Margin|Operating Profitability eupraxiapharma.com|BioHarvest Sciences (BHST) - Profitability of Operations|Operating Profitability Invizyne (EXOZ)|ORMP - Operating Return on Sales|Operating Margin ENTX (Entera Bio)|Operating Profitability Margin MindWalk Therapeutics|ABVC: Operating Sales Margin|CPIX - Operating Margin|QNTM (Quantum BioPharma) - Operating Sales Margin|Operating Profit Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operating Margin|Operating Margin ranitherapeutics.com|Operating Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.